The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Cherepakhin D.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Springer M.

Cardiovascular Research Institute and Institute of Regeneration Medicine, University of California, San Francisco, CA, USA

Sussman M.

San Diego State University Heart Institute, San Diego State University, San Diego, CA, USA

Shved P.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Bukina Yu.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Lichtenberg A.

Department of Cardiovascular Surgery, Cardiovascular Research Institute, Heinrich Heine University, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany

Belostotskaya G.

I.M.Sechenov Institute for Evolutionary Physiology and Biochemistry RAS, St. Petersburg, Russia

Zhegalova I.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Bakay M.

University of California in San Francisco, San Francisco, CA, USA

Tyukavin A.

St.Petersburg State Chemical-Pharmaceutical Academy, St. Petersburg, Russia

Song Sh.

Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL, USA

Charchyan E.

acad. B.V.Petrovsky Russian Research Center of Surgery RAS, Moscow, Russia

Reading Chr.

Harbor Therapeutics, San Diego, CA, USA

Suchkov S.

Chair of Clinical Immunology, A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia;
I.M.Sechenov First Moscow State Medical University, Moscow, Russia;
EPMA, Dundee, Great Britain

Preventive-prophylactic and therapeutic rehabilitation activities in post-MI patients monitoring: the reality of today and tomorrow’s out of sight

Authors:

Cherepakhin D., Springer M., Sussman M., Shved P., Bukina Yu., Lichtenberg A., Belostotskaya G., Zhegalova I., Bakay M., Tyukavin A., Song Sh., Charchyan E., Reading Chr., Suchkov S.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(1): 4‑7

DOI: 10.17116/kardio2016914-7

Read: 861 times

Download PDF (RU)
Contact the author
Table of contents

PREVENTIVE-PROPHYLACTIC AND THERAPEUTIC REHABILITATION ACTIVITIES IN POST-MI PATIENTS MONITORING: THE REALITY OF TODAY AND TOMORROW’S OUT OF SIGHT
PREVENTIVE-PROPHYLACTIC AND THERAPEUTIC REHABILITATION ACTIVITIES IN POST-MI PATIENTS MONITORING: THE REALITY OF TODAY AND TOMORROW’S OUT OF SIGHT

To cite this article:

Cherepakhin D, Springer M, Sussman M, et al. . Preventive-prophylactic and therapeutic rehabilitation activities in post-MI patients monitoring: the reality of today and tomorrow’s out of sight. Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(1):4‑7. (In Russ.)
https://doi.org/10.17116/kardio2016914-7

ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Predictors of myocardial infa­rction in patients with stable peri­pheral artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):61-65
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
Myocardial infa­rction in young age. Russian Journal of Preventive Medi­cine. 2024;(11):77-84
Expe­rimental substantiation of medi­cal device design for mechanical processing of adipose tissue. Piro­gov Russian Journal of Surgery. 2024;(12-2):101-108
Treatment of knee osteoarthritis with auto­logous stro­mal-vascular fraction of adipose tissue. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):27-37
Standardized and scalable method for stro­mal-vascular fraction harvesting from adipose tissue. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):76-81
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120
Uveal mela­noma and its local inflammation — good or bad for the patient?. Russian Annals of Ophthalmology. 2025;(1):5-12
Prevalence and role of elevated serum lipo­protein(a) in patients with myocardial infa­rction acco­rding to the Russian regi­ster of acute myocardial infa­rction REGION-MI. Russian Cardiology Bulletin. 2025;(1):39-48
The role of some markers of the infe­ctious process in the early diagnosis and evaluation of the effe­ctiveness of anti­biotic therapy in obstetric sepsis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):15-20
Abstract:

Keywords:

myocardial infarction
postinfarction period
biomarker
stem cells
progenitor cells of cardiomyocytes
regenerative medicine

Authors:

Cherepakhin D.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Springer M.

Cardiovascular Research Institute and Institute of Regeneration Medicine, University of California, San Francisco, CA, USA

Sussman M.

San Diego State University Heart Institute, San Diego State University, San Diego, CA, USA

Shved P.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Bukina Yu.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Lichtenberg A.

Department of Cardiovascular Surgery, Cardiovascular Research Institute, Heinrich Heine University, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany

Belostotskaya G.

I.M.Sechenov Institute for Evolutionary Physiology and Biochemistry RAS, St. Petersburg, Russia

Zhegalova I.

I.M.Sechenov First Moscow State Medical University, Moscow, Russia

Bakay M.

University of California in San Francisco, San Francisco, CA, USA

Tyukavin A.

St.Petersburg State Chemical-Pharmaceutical Academy, St. Petersburg, Russia

Song Sh.

Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL, USA

Charchyan E.

acad. B.V.Petrovsky Russian Research Center of Surgery RAS, Moscow, Russia

Reading Chr.

Harbor Therapeutics, San Diego, CA, USA

Suchkov S.

Chair of Clinical Immunology, A.I.Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia;
I.M.Sechenov First Moscow State Medical University, Moscow, Russia;
EPMA, Dundee, Great Britain

Close metadata

References:

  1. Andersen DC, Andersen P, Schneider M, Jensen HB, Sheikh SP. Murine <> are not a source of stem cells with cardiomyogenic potential. Stem Cells. 2009;27(7):1571-1581. doi: 10.1002/stem.72
  2. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013;61(23):2329- 2338. doi: 10.1016/j.jacc.2013.02.071
  3. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin S-CJ, Middleton RC, Marban E, Molkentin JD. c-kit + cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509(7500):337-341. doi: 10.1038/nature13309
  4. Biber B, Cook SM, Palpant NJ, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, Astley CA, Hotchkiss CE, Baldessari A, Pabon L, Reinecke H, Gill EA, Nelson V, Kiem H-P, Laflamme MA, Murry CE. Human embryonic-stemcell- derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014;510(7504):273-277. doi: 10.1038/nature13233
  5. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378(9806):1847- 1857. doi: 10.1016/s0140-6736 (11)61590-0
  6. Challen GA, Boles NC, Chambers SM, Goodell MA. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell. 2010;6(3):265-278. doi: 10.1016/j.stem.2010.02.002
  7. Choi WY, Poss KD. Cardiac regeneration. Curr Top Dev Biol. 2012;100:319-344. doi: 10.1016/b978-0-12-387786- 4.00010-5
  8. Chong JJH, Murry CE. Cardiac regeneration using pluripotent stem cells - progression to large animal models. Stem Cell Res. 2014. doi: 10.1016/j.scr.2014.06.005
  9. Friis T, Haack-Sorensen M, Mathiasen AB, Ripa RS, Kristoffersen US, Jorgensen E, Hansen L, Bindslev L, Kjaer A, Hesse B, Dickmeiss E, Kastrup J. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina. Scand Cardiovasc J. 2011;45(3):161-168. doi: 10.3109/14017431.2011.569571
  10. Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zambrano JP, Fishman J, Pattany P, McNiece I, Conte J, Schulman S, Wu K, Shah A, Breton E, Davis-Sproul J, Schwarz R, Feigenbaum G, Mushtaq M, Suncion VY, Lardo AC, Borrello I, Mendizabal A, Karas TZ, Byrnes J, Lowery M, Heldman AW, Hare JM. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res. 2014;114(8):1302-1310. doi: 10.1161/circresaha.114.303180
  11. Klaus A, Muller M, Schulz H, Saga Y, Martin JF, Birchmeier W. Wnt/betacatenin and Bmp signals control distinct sets of transcription factors in cardiac progenitor cells. Proc Natl Acad Sci USA. 2012;109(27):10921-10926. doi: 10.1073/pnas.1121236109
  12. Nowbar AN, Mielewczik M, Karavassilis M, Dehbi H-M, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction: weighted regression and metaanalysis. DAMASCENE. 2014;348. doi: 10.1136/bmj.g2688
  13. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012;307(16):1717-1726. doi: 10.1001/jama.2012.418
  14. Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, Wagenknecht L, Ni H, Folsom AR. Twenty- two-year trends in incidence of myocardial infarction, coronar heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation. 2012;125(15):1848-1857. doi: 10.1161/circulationaha.111.047480
  15. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379(9817):713-720. doi: 10.1016/s0140-6736(12)60028-2
  16. Sheng CC, Zhou L, Hao J. Current stem cell delivery methods for myocardial repair. Biomed Res Int. 2013;2013:547902. doi: 10.1155/2013/547902
  17. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4(8):929-933.
  18. Templin C. et al, 2010; Georg Ertl T. et al. 2005.
  19. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013;127(2):213-223. doi: 10.1161/circulationaha.112.131110
  20. Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350):212- 215. doi: 10.1038/nature10135
  21. Tyukavin А.I., Belostotskaya G.B., Golovanova T.А., Galagudza M.M., Zakharov E.А., Burkova N.V., Ivkin D.YU., Karpov А.А. Stimulation of proliferation and differentiation of resident myocardial cells of rats using cardiomyocyte apoptotic bodies. Kletochnye tekhnologii v biologii i meditsine. 2015;1:25-29.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.